pentoxifylline has been researched along with Pulmonary Consumption in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliev, RS | 1 |
| Agaev, FF | 1 |
| Alieva, LP | 1 |
| Kibrik, BS | 1 |
| Chelnokova, OG | 1 |
| Zabel, P | 2 |
| Schade, FU | 2 |
| Schlaak, M | 2 |
| Wallis, RS | 2 |
| Nsubuga, P | 2 |
| Whalen, C | 1 |
| Mugerwa, RD | 2 |
| Okwera, A | 2 |
| Oette, D | 1 |
| Jackson, JB | 1 |
| Johnson, JL | 2 |
| Ellner, JJ | 2 |
| Whalen, CC | 1 |
| Turner, J | 1 |
| Frank, AA | 1 |
| Brooks, JV | 1 |
| Marietta, PM | 1 |
| Orme, IM | 1 |
1 review available for pentoxifylline and Pulmonary Consumption
| Article | Year |
|---|---|
Inhibition of endogenous TNF formation by pentoxifylline.
Topics: Animals; Cells, Cultured; Cytokines; Humans; Indomethacin; Kidney Transplantation; Leukopenia; Lipop | 1993 |
2 trials available for pentoxifylline and Pulmonary Consumption
| Article | Year |
|---|---|
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial.
Topics: Adult; beta 2-Microglobulin; Double-Blind Method; HIV Seropositivity; Humans; Pentoxifylline; Phosph | 1996 |
Pentoxifylline in human immunodeficiency virus- positive tuberculosis: safety at 4 years.
Topics: AIDS-Related Opportunistic Infections; Follow-Up Studies; HIV Infections; Humans; Pentoxifylline; Re | 1998 |
4 other studies available for pentoxifylline and Pulmonary Consumption
| Article | Year |
|---|---|
[Use of trental for correction of disorders in the system of hemostasys in patients with fibro-cavernous tuberculosis and chronic pulmonary heart].
Topics: Antithrombins; Blood Coagulation; Cell Aggregation; Fibrin; Fibrinogen; Humans; Lung; Pentoxifylline | 2012 |
[Extracorporeal antiaggregant pharmacotherapy in the treatment of acutely progressive forms of tuberculosis].
Topics: Antitubercular Agents; Blood Chemical Analysis; Disease Progression; Drug Therapy, Combination; Huma | 2007 |
Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology.
Topics: Animals; Chemokine CCL2; Chronic Disease; Disease Progression; Female; Interferon-gamma; Lung; Mice; | 2001 |
[Pentoxifylline--an inhibitor of the synthesis of tumor necrosis factor alpha].
Topics: Adult; Animals; Cells, Cultured; Endotoxins; Humans; Kidney Transplantation; Macrophages; Mice; Muro | 1992 |